Skip to main content

Posters

Showing 1 of 4

New

Dupilumab Reduces the Risk of Severe Exacerbations in Patients With Chronic Obstructive Pulmonary Disease

Confidential. For use by Medical Affairs for scientific exchange purposes only. Do not copy or distribute. Some information may not be consistent with the approved product labelling for the product(s) being discussed; this information may relate to the indication or use, dosage and administration, patient population, combination use, or other potential unapproved uses. No conclusions regarding safety and efficacy can be made for such uses.